@inbook{12c97327bc434731a4956aea2a44c4dd,
title = "Racial disparities in pancreatic cancer clinical trials: Defining the problem and identifying solutions",
abstract = "Underrepresented minority patients with pancreatic cancer have differential access to cancer treatments, including clinical trials. The successful conduct and completion of clinical trials is critical to improve outcomes for patients with pancreatic cancer. Therefore, it is essential to consider how to maximize eligibility of patients for both therapeutic and non-therapeutic clinical trials. It is important for clinicians and for the health system to understand individual-, clinician-, and system-level barriers to recruitment, enrollment, and completion of clinical trials to alleviate bias. Understanding strategies that lead to improved enrollment of underrepresented minorities, socioeconomically disadvantaged individuals, and underserved communities will improve generalizability of cancer clinical trials and advance health equity.",
keywords = "Cancer disparities, Clinical trials, Pancreas cancer, Pancreatic ductal adenocarcinoma",
author = "Martin, {Allison N.} and Snyder, {Rebecca A.}",
note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",
year = "2023",
month = jan,
doi = "10.1016/bs.acr.2023.02.009",
language = "English (US)",
isbn = "9780443133541",
series = "Advances in Cancer Research",
publisher = "Academic Press Inc.",
pages = "185--201",
editor = "Luni Emdad and Azeddine Atfi and Rajan Gogna and Trevino, {Jose G.} and Fisher, {Paul B.}",
booktitle = "Pancreatic Cancer",
}